Biontech Stock – Moderna, Inc. (MRNA) Stock price, News, Quote & History

Initial doses of Moderna‘s
MRNA,
-1.59%
COVID-19 vaccine were being administered in Wales on Wednesday. The vaccine is the UK.’s third to be approved for use, after the one developed jointly by BioNTech
bntch
and Pfizer
PFE,
-0.14%,
and the one from AstraZeneca
((AZN)),
-0.99%
((AZN)),
-0.89%
and its partner Oxford University. The UK. has bought enough Moderna shots for 8.5 million people, or 17 million doses of the vaccine that was shown to be 100% effective against a severe form of the virus in late-stage trials. “Please get your jab as soon as you are contacted,” said Prime Minister Boris Johnson in a tweet on Wednesday. The Moderna rollout came following a pause Tuesday on UK. trials of the AstraZeneca vaccine in children amid a probe into a possible link between those shots and blood clots in adults.